PAYD.OTC.PinkPaid INC

10-Q: PAID Inc. Q2 2025: Revenue Up, Net Loss Widens

Sentiment:

Quarterly Report


PAID Inc. reported an 18% increase in Q2 2025 revenues driven by shipping coordination services, but posted a net loss of $397,349 due to higher operating expenses and reduced other income.

Delay expectedThe repayment date for the Embolx note receivable, which management relies on for liquidity, is uncertain, despite an extension until September 30, 2025.The results of the post-trial arguments in the legal dispute with Mr. Allan Pratt, heard on June 10, 2025, have not yet been released.
Capital raiseManagement "may seek alternative sources of capital to support the growth of future operations" if anticipated growth does not occur or new products are not successful.
Worse than expectedNet income shifted from a profit of $770,452 in Q2 2024 to a loss of $397,349 in Q2 2025.Net income shifted from a profit of $1,069,890 in YTD Q2 2024 to a loss of $546,122 in YTD Q2 2025.Total operating expenses increased by 36% in Q2 2025, primarily due to a significant rise in share-based compensation.Other income decreased by 99% in Q2 2025, largely due to the deferral of interest and penalties from the Embolx note receivable, which had boosted prior year's income.Cash and cash equivalents decreased by $216,846 during the six months ended June 30, 2025.The company continues to incur losses and has an accumulated deficit of $69,420,148, raising substantial doubt about its ability to continue as a going concern.

Summary

  • Net revenues for the three months ended June 30, 2025, increased by 18% to $5,428,025 from $4,603,299 in the prior year.
  • Net revenues for the six months ended June 30, 2025, increased by 12% to $9,805,817 from $8,764,048 in the prior year.
  • Shipping coordination and label generation services revenue increased by 18% in Q2 2025 and 12% for the six months, driven by shifts from Canada Post and strategic pricing.
  • eCommerce services revenue increased by 77% in Q2 2025 and 94% for the six months, attributed to successful marketing of PaidShipping.
  • Client services revenue decreased by 65% in Q2 2025 and 69% for the six months, due to client cancellations and the announced closing of BeerRun Software.
  • Gross profit increased by $94,084 in Q2 2025 to $1,201,653, but gross margin decreased from 24% to 22%.
  • Total operating expenses increased by 36% in Q2 2025 to $1,608,965, primarily due to a significant increase in share-based compensation.
  • Net loss for Q2 2025 was $397,349, compared to a net income of $770,452 in Q2 2024.
  • Net loss for the six months ended June 30, 2025, was $546,122, compared to a net income of $1,069,890 in the prior year.
  • Cash and cash equivalents decreased to $1,068,119 at June 30, 2025, from $1,284,965 at December 31, 2024.
  • Working capital deficit improved slightly to $577,380 at June 30, 2025, from $629,467 at December 31, 2024.
  • The company continues to incur losses and has a significant accumulated deficit of $69,420,148, raising substantial doubt about its ability to continue as a going concern.
  • Management believes it has adequate cash for the next 12 months, partly relying on the uncertain repayment of the Embolx note receivable.
  • The CEO/CFO identified material weaknesses in internal control over financial reporting as of June 30, 2025.

Sentiment

Score: 3

Explanation: While revenue growth in shipping and eCommerce is positive, the company's shift from net income to significant net losses, driven by increased operating expenses and reduced other income, is a major negative. The "going concern" doubt, substantial accumulated deficit, and identified material weaknesses in internal controls present significant risks. The reliance on an uncertain note repayment for liquidity further dampens sentiment.

Positives

  • Net revenues increased by 18% in Q2 2025 and 12% for the six months ended June 30, 2025, demonstrating top-line growth.
  • Shipping coordination and label generation services, the largest segment, saw an 18% revenue increase in Q2 2025 and 12% for the six months, driven by market shifts and strategic pricing.
  • eCommerce services revenue grew significantly by 77% in Q2 2025 and 94% for the six months, indicating strong performance in this segment.
  • Gross profit increased by $94,084 in Q2 2025 and $95,803 for the six months, despite a slight decrease in gross margin percentage.
  • Working capital deficit decreased by $52,087, improving the company's short-term liquidity position.
  • Management believes it has adequate cash resources to fund operations for the next 12 months.
  • The Embolx note receivable, valued at $5,967,100, is secured by substantially all assets of Embolx, and the company expects it to be recoverable upon a financial or merger transaction in 2025 or 2026.

Negatives

  • The company reported a net loss of $397,349 in Q2 2025, a significant decline from a net income of $770,452 in Q2 2024.
  • The net loss for the six months ended June 30, 2025, was $546,122, compared to a net income of $1,069,890 in the prior year.
  • Operating expenses increased substantially by 36% in Q2 2025 and 25% for the six months, primarily due to a large increase in share-based compensation ($510,622 in Q2 2025 vs. $2,678 in Q2 2024).
  • Other income decreased by 99% in Q2 2025 and 98% for the six months, largely due to deferring interest and penalties related to the Embolx note receivable, which had contributed significantly to income in the prior year.
  • Cash and cash equivalents decreased by $216,846 during the six months ended June 30, 2025.
  • The company continues to incur losses and has an accumulated deficit of $69,420,148, raising substantial doubt about its ability to continue as a going concern.
  • Client services revenue decreased significantly by 65% in Q2 2025 and 69% for the six months, due to client cancellations and the announced closing of the BeerRun Software.
  • The repayment date for the Embolx note receivable is uncertain, despite management's reliance on it for liquidity.
  • The CEO/CFO concluded that disclosure controls and procedures were not effective due to material weaknesses in internal control over financial reporting.

Risks

  • **Going Concern Risk**: The company has continued to incur losses, reported a net loss of $546,122 for the six months ended June 30, 2025, and has an accumulated deficit of $69,420,148, raising substantial doubt about its ability to continue as a going concern.
  • **Liquidity Risk**: While management believes it has adequate cash for the next 12 months, this relies on the uncertain repayment of the Embolx note receivable and potential reductions in business costs.
  • **Operational Risk**: There is no assurance that anticipated growth in new business will occur or that the company will be successful in launching new products and services.
  • **Customer Concentration Risk**: The company derived approximately 99% of its revenues from Canada and 1% from the U.S. during the six months ended June 30, 2025 and 2024, indicating high geographic concentration.
  • **Long-Lived Asset Impairment Risk**: No impairment charges were recognized, but there is no assurance that market conditions will not change or demand for services will continue, which could result in impairment in the future.
  • **Legal Proceedings Risk**: The company is involved in a legal dispute with its former President, CEO, and Chairman, Mr. Allan Pratt, regarding a severance payment and a stock bonus awarded to the current CEO. The outcome of these matters cannot be determined, and no reserve has been recorded.
  • **Internal Control Weaknesses**: Material weaknesses in internal control over financial reporting have been identified, impacting the effectiveness of disclosure controls and procedures.
  • **Forward-Looking Statement Risks**: The company's ability to maintain positive cash flow and become profitable may be adversely affected by factors such as inability to implement its business model, higher costs, insufficient customer sales, competition, failure to attract site traffic, inability to complete product development, operating system failures, and inability to increase revenues as rapidly as anticipated.

Future Outlook

Management believes it has adequate cash resources to fund operations during the next 12 months, with the repayment of the Embolx note receivable expected to alleviate liquidity concerns, though its repayment date is uncertain. The company plans to significantly reduce business costs to eliminate net losses and achieve positive cash flow from operations. Management continues to explore opportunities and has organized additional resources to grow the Paid platform, but there is no assurance that anticipated growth or successful new product launches will occur. Alternative sources of capital may be sought to support future operations. The company believes its plans will be sufficient to meet working capital requirements through August 2026.

Management Comments

  • "Management believes that the Company has adequate cash resources to fund operations during the next 12 months after the filing of this quarterly report on Form 10-Q."
  • "The repayment of the Embolx note receivable will alleviate the concern however the repayment date is uncertain."
  • "Additionally, the costs of doing business can be significantly reduced in hopes of eliminating the net loss and providing positive cash flow from operations."
  • "Management continues to explore opportunities and has organized additional resources to grow the Paid platform."
  • "Although there can be no assurances, the Company believes that the above management plans will be sufficient to meet the Companys working capital requirements through the end of August 2026 and will have a positive impact on the Company for the foreseeable future."
  • "Our focus in 2025 will be to continue to grow this portion of our business [ShipTime]."
  • "The Company has identified numerous material weaknesses in internal control over financial reporting as described in the Company's Form 10-K for the year ended December 31, 2024."
  • "Based upon this evaluation, the Chief Executive Officer/Chief Financial Officer has concluded that, as of June 30, 2025, the Company's disclosure controls and procedures were not effective, due to material weaknesses in internal control over financial reporting."

Industry Context

The company operates in the competitive SaaS-based business services sector, focusing on SMBs for website creation, online sales, payment collection, and shipping. Its shipping coordination segment benefited from uncertainty surrounding Canada Post delivery services due to pending contract negotiations, leading to a shift towards alternative carriers. This indicates a dynamic market where external factors can significantly influence segment performance. The closure of the BeerRun Software for brewery management suggests a strategic decision to exit less profitable or non-core offerings, a common practice in evolving SaaS markets. The growth in eCommerce services aligns with broader industry trends of increasing online transactions and demand for integrated digital solutions for small businesses.

Comparison to Industry Standards

  • The company's gross margin of 22-23% is lower than typical SaaS industry benchmarks, which often range from 70-80% or higher, indicating a significant portion of revenue is passed through as cost of goods sold, particularly in its shipping coordination segment. This suggests a business model more akin to a reseller or facilitator rather than a pure software provider for its primary revenue driver.
  • The substantial increase in share-based compensation, leading to a net loss, contrasts with the focus on profitability and efficient capital allocation often seen in mature SaaS companies.
  • The ongoing "going concern" doubt and accumulated deficit of over $69 million are significant red flags compared to financially stable industry peers.
  • The reliance on a single large note receivable (Embolx) for future liquidity, with an uncertain repayment date, is a higher-risk strategy than typically observed in well-capitalized companies.
  • The identified material weaknesses in internal control over financial reporting are below industry best practices for public companies, which prioritize robust financial controls.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
CEO/CFON/AW. Austin Lewis, IV2025-05-15Renewal bonus of 250,000 shares authorized, with 125,000 immediately vested and the remainder vesting ratably through January 1, 2027.
Board MembersN/AThree board members2025-05-15Issuance of options to purchase 55,000 shares of common stock.
CEO/CFO, Officer, Two EmployeesN/AW. Austin Lewis, IV, one additional officer, two employees2025-03-07Issuance of 62,502 bonus shares for services rendered during 2024.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control WeaknessesThe CEO/CFO concluded that disclosure controls and procedures were not effective as of June 30, 2025, due to material weaknesses in internal control over financial reporting. The company continues to evaluate and work towards implementation of corporate governance and operational process documentation.2025-06-30Significant negative impact on financial reporting reliability and compliance, requiring remediation efforts.
Board Size Dispute ResolutionDelaware courts dismissed the claim contesting the reduction of the board size from five to three members, which had resulted in Mr. Pratt and Mr. Austin Lewis rolling off the board.2023-11-09Resolved a governance dispute, affirming the board's decision on its size.

Legal Proceedings

  • The company is involved in a legal dispute with Mr. Allan Pratt, its former President, CEO, and Chairman, regarding a severance payment he alleges is due following the non-renewal of his employment agreement.
  • Mr. Pratt's amended complaint also disputes the proper authorization of a stock bonus awarded to the current CEO in March 2021.
  • The Delaware courts dismissed Mr. Pratt's claim contesting the reduction of the board size on November 9, 2023.
  • A trial on the remaining claim (severance and stock bonus) was held before the Delaware court on December 5-6, 2024.
  • Post-trial briefing was completed on March 21, 2025, and post-trial arguments were heard on June 10, 2025.
  • The results of the post-trial arguments have not yet been released.
  • The company has not recorded a reserve for this matter as the outcome cannot be determined.

Related Party Transactions

  • Issuance of 250,000 bonus shares of common stock to the CEO/CFO on May 15, 2025, as a renewal bonus valued at $747,500. $373,750 of share-based compensation expense was recognized immediately, with the remaining $373,750 to be recognized ratably through January 1, 2027.
  • Issuance of 62,502 bonus shares of common stock to the CEO/CFO, one additional officer, and two employees on March 7, 2025, for services rendered during 2024, valued at $193,246.
  • Issuance of options to purchase 55,000 shares of common stock to three board members on May 15, 2025, with an exercise price of $2.99 per share and immediate vesting.

Stakeholder Impact

  • **Shareholders**: Experience dilution from significant share-based compensation awards to management and board members. The net loss and "going concern" doubt could negatively impact share value. The uncertainty around the Embolx note repayment also poses a risk.
  • **Employees**: The company's focus on reducing costs could lead to workforce adjustments. Share-based compensation provides incentives for key personnel.
  • **Customers**: Shifts in shipping volume from Canada Post to other carriers indicate a dynamic environment for customers seeking reliable and cost-effective shipping solutions. The closure of BeerRun Software impacts brewery management clients.
  • **Creditors**: The "going concern" doubt and reliance on uncertain note repayment could raise concerns for existing and potential creditors. The Embolx note is secured, which provides some protection for that specific debt.
  • **Management**: Significant share-based compensation provides incentives, but the responsibility for addressing financial losses, liquidity concerns, and internal control weaknesses falls on them.

Next Steps

  • Management plans to significantly reduce business costs to eliminate net losses and provide positive cash flow from operations.
  • Management will continue to explore opportunities and organize additional resources to grow the Paid platform.
  • Management may seek alternative sources of capital to support the growth of future operations if needed.
  • The Embolx note receivable is due on September 30, 2025, with potential options for further extension.
  • The remaining $75,000 investment in 5String Solutions is due on or before October 7, 2025.
  • The company will continue to evaluate internal controls over financial reporting and work towards implementation of corporate governance and operational process documentation.
  • The Delaware court's decision on the legal claim regarding the CEO's stock bonus is pending release.

Key Dates

DateDescription
2018-03-23Board of Directors approved the 2018 Stock Option Plan, reserving 450,000 non-qualified stock options.
2019PAID Payments began operating as a Payment Facilitator.
2020-02-01ShipTime Canada amended its rights to exchange one share of ShipTime Canada stock for 356 PAID common shares.
2020-02-29Period for additional conversion of Series A Preferred Stock to Common Stock related to ShipTime acquisition.
2020-11-10Board voted to increase the 2018 Stock Option Plan from 450,000 to 900,000 options.
2021Mr. Allan Pratt filed a claim in Delaware courts contesting the board reduction and later amended it to dispute a stock bonus.
2021-12Company had the option to force an exchange of ShipTime shares for PAID common stock.
2022-07Mr. Pratt amended his complaint to dispute the proper authorization of a stock bonus awarded to the CEO in March 2021.
2022-10-13Company entered into a Securities Purchase Agreement (SPA) for a $1,875,000 convertible note with Embolx, Inc.
2023-03-21Board authorized issuance of 46,961 bonus shares to CEO/CFO, officer, and employee for 2022 services, valued at $82,180.
2023-03-21Board authorized issuance of an additional 250,000 shares to CEO/CFO as a renewal bonus, valued at $437,500.
2023-07-19Embolx note was in default, carrying additional 20% penalty and 20% interest.
2023-11-09Delaware courts dismissed Mr. Pratt's claim contesting the reduction of the board size.
2023-11FASB issued ASU 2023-07, Segment Reporting, effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024.
2023-12FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, effective for fiscal years beginning after December 15, 2024.
2024-01-01Company adopted ASU 2023-09 and ASU 2023-07.
2024-02Company repurchased 3,996 shares of common stock for $3,996.
2024-02-22Board authorized issuance of 54,559 bonus shares to CEO/CFO, officer, and employee for 2023 services, valued at $84,576.
2024-02-22Board approved issuance of options to purchase 45,360 shares of common stock to three board members and five employees.
2024-03Company amended and replaced the Embolx note and terminated warrants.
2024-04-04Company entered into a $50,000 short-term note with 5String Solutions LLC.
2024-06-19Amended Embolx note receivable was in default in the amount of $4,193,607.
2024-07-02Company entered into an operating lease for its corporate office in Oakville, Ontario, commencing September 1, 2024.
2024-07-035String Solutions note amended to include an additional $198,500 investment, resulting in a $250,000 long-term note due April 30, 2027.
2024-07-29Board of Directors approved an extension with Embolx, effective January 31, 2025.
2024-09-01Corporate office lease commenced.
2024-12-05Trial on Mr. Pratt's remaining claim held before the Delaware court.
2024-12-06Trial on Mr. Pratt's remaining claim concluded.
2025-01-31Forbearance and Loan Modification Agreement with Embolx became effective, extending the note receivable until September 30, 2025.
2025-03-07Board authorized issuance of 62,502 bonus shares to CEO/CFO, officer, and two employees for 2024 services, valued at $193,246.
2025-03-21Post-trial briefing in the Delaware action regarding Mr. Pratt's claim was completed.
2025-05-15Board authorized issuance of 250,000 bonus shares to CEO/CFO as a renewal bonus, valued at $747,500.
2025-05-15Board approved issuance of options to purchase 55,000 shares of common stock to three board members.
2025-06Announcement of the closing of BeerRun Software.
2025-06-10Delaware court heard post-trial arguments on Mr. Pratt's claim.
2025-06-30End of the quarterly reporting period.
2025-07-01Company amended its note with 5String Solutions to include new payment terms on an additional $150,000 investment.
2025-07-01Company made an additional investment of $75,000 in 5String Solutions.
2025-08-14Date of filing of the 10-Q report.
2025-09-30Extended due date for the Embolx note receivable.
2025-10-07Due date for the remaining $75,000 investment in 5String Solutions.
2026-08-31Management believes current plans will be sufficient to meet working capital requirements through this date.
2027-01-01Repurchase period for 125,000 CEO/CFO bonus shares ends.
2027-04-30Due date for the 5String Solutions long-term note.
2028-08-31Expiration date of the corporate office operating lease.

Recommendation

sell

The company's shift from net income to significant net losses, coupled with a substantial accumulated deficit and "going concern" doubt, indicates severe financial distress. While revenue growth in some segments is positive, it's overshadowed by soaring operating expenses (largely share-based compensation) and a dramatic reduction in other income. The identified material weaknesses in internal controls are a serious governance issue. The reliance on an uncertain note repayment for liquidity adds further risk. For a seasoned investor, these factors point to a highly speculative investment with significant downside risk and a lack of clear path to sustainable profitability, warranting a "sell" recommendation.

Keywords

SaaS, Shipping coordination, eCommerce, Payment processing, Web hosting, Small and medium business (SMB), Canada Post, Financial results, Quarterly report, SEC filing, Going concern, Share-based compensation, Embolx note, Internal controls

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.